Cue biopharma inc.

Major-Pharmaceuticals

CUE


21 Erie Street
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 1.39
    $ +0.32 29.91 %
    Jan 3, 2025
  • 52-Week High/Low
  • $3.1 - $0.6
  • YTD
  • 28.7%

  • Trading Volume
  • 27,650
  • Market Cap Full
  • $ 62.7M
  • Shares Outstanding
  • 45.1M
    Nov 1, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - 64.5% -5% -3% -57% 25.3% -27.7% 28.7%
Q2 - - -14.7% -3.3% 4% -4% -49.1% 2.2% -27.4% -
Q3 - - -23% 1.6% 8% 25.1% -10.4% -37% -20% -
Q4 - - -46.2% 76.3% -16.9% -22% 27.8% 25.4% -41.9% -
J F M A M J J A S O N D
2025 28.7% - - - - - - - - - - -
2024 - -21.4% -8% -17.8% 3.8% -15.3% -34.8% -20% - - - -10%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%239%-22%-9%-75%-7%-59%29%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.37 -0.54 -0.48 -0.41 -0.44 -0.29
Q2 - - -0.36 -0.46 -0.38 -0.33 -0.37 -0.29
Q3 - - -0.62 -0.31 -0.34 -0.41 -0.31 -0.24
Q4 - - -0.59 -0.35 -0.36 -0.26 -0.37 -
A 0 0 -1.9 -1.7 -1.6 -1.4 -1.5 -0.82

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 20.7 26.6 30.5 33 43.2
Jun 20.1 20.8 28.4 31.4 35.4 43.2
Sep 20.1 22.6 29.5 31.5 35.4 45
Dec 20.1 23 30.3 31.8 35.4 45.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 3 0.6 0.6 0.2
Total Asset Turnover - 0.2 - - -
Leverage
Debt Ratio 0.1 - - - -
Debt – Equity Ratio 0.1 - - - -
Interest Coverage - - - - -
Equity multiplier 0.1 0.1 0.1 0.1 0.2